Bio-Organic Solutions, Inc. – Trademark Portfolio
Entity Type: 03
Bio-Organic Solutions, Inc. holds 21 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 1 (Chemicals) — 20 filings in this category. The portfolio also extends into Class 36 (Insurance & Financial) across 2 Nice Classification classes. Currently, 6 trademarks are registered. Notable registered marks include COCONOT, VERMIFIRE, VERMISOIL, VERMIBLEND, and VERMIFEAST. The owner is based in Olivehurst, CA.
5050 Arboga Road
Olivehurst, CA 959619997
Showing of trademarks Trademarks
Trademark Classifications
Bio-Organic Solutions, Inc.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Chemical products for industry, science, photography, agriculture, horticulture and forestry
Insurance; financial affairs; monetary affairs; real estate affairs
Frequently Asked Questions
How many trademarks does Bio-Organic Solutions, Inc. have?
Bio-Organic Solutions, Inc. has 21 U.S. trademarks filed with the USPTO. Of these, 6 registered, 3 abandoned, 12 cancelled.
What trademark classes does Bio-Organic Solutions, Inc. file in?
Bio-Organic Solutions, Inc. files trademarks across 2 Nice Classification classes. The most active classes are Class 1 (Chemicals), Class 36 (Insurance & Financial). Class 1 covers chemical products for industry, science, photography, agriculture, horticulture and forestry.
What are Bio-Organic Solutions, Inc.'s most well-known trademarks?
Bio-Organic Solutions, Inc.'s registered trademark portfolio includes well-known marks such as COCONOT, VERMIFIRE, VERMISOIL, VERMIBLEND, and VERMIFEAST. These are among 6 currently registered trademarks in the portfolio.
What is Bio-Organic Solutions, Inc.'s trademark registration success rate?
Bio-Organic Solutions, Inc. has a 29% trademark registration rate, with 6 out of 21 resolved applications resulting in successful registration. Currently, 0 applications are pending review.